Andrea Calcagno

55PUBLICATIONS
118CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Central nervous systemPharmaceutical delivery technologiesInnate immunityMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (55)

|Sep 11, 2026
The effect of a tailored dietary intervention on serum biomarkers and faecal microbiome composition in people with HIV at risk of cardiovascular disease.

|Apr 16, 2026
Longitudinal changes in plasma biomarkers of immune activation, neuronal inflammation and injury in persons with HIV initiating ART.

|Apr 06, 2026
The plasma and intracellular exposure of intramuscularly administered long-acting cabotegravir and rilpivirine in people with HIV.

Micol Ferrara, Viviana Maccario, Federica Barrera

|Mar 18, 2026
Early Combination Antiretroviral Therapy Initiation During Primary HIV Infection Restricts HIV Reservoirs and Gut-Driven Inflammation but Fails to Rewire the Systemic Cytokine Landscape.

Valeria Bono, Camilla Tincati, Matteo Augello

|Feb 27, 2026
Molecular Techniques for MTBC and NTM Differentiation: Diagnostic Accuracy of STANDARD™ M10 MTB/NTM and Potential Applications.

Mattia Genco, Silvia Alizzi, Paolo Valesella

|Jan 19, 2026
Bimonthly Administered Long-Acting Cabotegravir and Rilpivirine Are Highly Effective and Well-Tolerated in People With Human Immunodeficiency Virus Above 65 Years.

Andrea Calcagno, Caterina Candela, Agostino Riva

Pageof 10

Frequent Collaborators

19 joint publications

Antonio D'Avolio

14 joint publications

Jessica Cusato

13 joint publications

Mattia Trunfio

11 joint publications

Amedeo De Nicolò